Vaxcyte (PCVX) Shares Issued (2019 - 2023)
Vaxcyte (PCVX) posted quarterly Shares Issued of $4.6 million for Q4 2023, down 39.77% year-over-year from $7.7 million in Q4 2022, and up 7.2% quarter-over-quarter from $4.3 million in Q3 2023.
Vaxcyte (PCVX) Shares Issued (2019 - 2023) Analysis & Trends
Vaxcyte (PCVX) has reported Shares Issued for 5 consecutive years, with $4.6 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Shares Issued fell 39.77% year-over-year to $4.6 million; the TTM figure through Dec 2023 stood at $4.6 million (down 39.77% YoY), while the FY2023 annual figure was $4.6 million, down 39.77% from the prior year.
- Shares Issued climbed to $4.6 million in Q4 2023 per PCVX's latest filing, from $4.3 million in the prior quarter.
- Across five years, Shares Issued topped out at $9.1 million in Q1 2023 and bottomed at $650000.0 in Q2 2020.
- Historically, Shares Issued has averaged $4.3 million across 5 years, with a median of $4.6 million in 2020.
- Annual changes were most pronounced in 2021 — Shares Issued soared 547.69% — and 2022, when it tumbled 62.85%.
- Vaxcyte's Shares Issued stood at $835941.0 in 2019, then soared by 456.4% to $4.7 million in 2020, then grew by 13.84% to $5.3 million in 2021, then jumped by 45.71% to $7.7 million in 2022, then slumped by 39.77% to $4.6 million in 2023.
- Business Quant data shows PCVX's Shares Issued at $4.6 million in Q4 2023, $4.3 million in Q3 2023, and $6.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vaxcyte | 8.41 Bn | 8.41 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 4.65 Mn |
| Dec 31, 2023 | 4.65 Mn |
| Sep 30, 2023 | 4.33 Mn |
| Sep 30, 2023 | 4.33 Mn |
| Jun 30, 2023 | 6.49 Mn |
| Jun 30, 2023 | 6.49 Mn |
| Mar 31, 2023 | 9.15 Mn |
| Mar 31, 2023 | 9.15 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Sep 30, 2022 | 4.69 Mn |
| Sep 30, 2022 | 4.69 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 7.16 Mn |
| Mar 31, 2022 | 7.16 Mn |
| Dec 31, 2021 | 5.30 Mn |
| Dec 31, 2021 | 5.30 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.10 Mn |